GTG.AX - Genetic Technologies Limited

ASX - ASX Delayed price. Currency in AUD
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/06/2019
30/06/2018
30/06/2017
30/06/2016
Cash flows from operating activities
Net income
-5,288
-6,426
-5,464
-8,404
-8,459
Depreciation & amortisation
-
-
304
372
390
Deferred income taxes
-
-
-
-
-
Stock-based compensation
-
-
130
120
50
Change in working capital
-
-
65
431
-56
Accounts receivable
-
-
125
205
84
Inventory
-
-
-
-
-
Accounts payable
-
-
47
60
-342
Other working capital
-6,075
-6,123
-5,624
-7,048
-8,030
Other non-cash items
-
-
-
665
-58
Net cash provided by operating activities
-
-
-5,621
-6,814
-7,727
Cash flows from investing activities
Investments in property, plant and equipment
-3
-50
-2
-235
-303
Acquisitions, net
-
-
-
-
-
Purchases of investments
-
-500
-
-
-
Sales/maturities of investments
-
-
-
-
-
Other investing activities
-
-
-
0
0
Net cash used for investing activities
-3
-524
-2
-182
-296
Cash flows from financing activities
Debt repayment
-
-
-
-
-
Common stock issued
1,350
3,558
0
8,049
0
Common stock repurchased
-
-
-
-
-
Dividends paid
-
-
-
-
-
Other financing activities
-3
-431
-10
-939
-2
Net cash used provided by (used for) financing activities
1,347
3,126
-10
7,110
-2
Net change in cash
-4,728
-3,471
-5,634
114
-8,025
Cash at beginning of period
7,594
5,487
10,988
11,180
18,341
Cash at end of period
2,866
2,132
5,487
10,988
11,180
Free cash flow
Operating cash flow
-
-
-5,621
-6,814
-7,727
Capital expenditure
-3
-50
-2
-235
-303
Free cash flow
-6,075
-6,123
-5,624
-7,048
-8,030